• Germany

German Biotech Stocks Analysis

XTRA:MDG1
XTRA:MDG1
XTRA:MDG1Biotechs

The Strong Earnings Posted By Medigene (ETR:MDG1) Are A Good Indication Of The Strength Of The Business

August 12, 2022
The subdued stock price reaction suggests that Medigene AG's ( ETR:MDG1 ) strong earnings didn't offer any surprises...
XTRA:MDG1
XTRA:MDG1
XTRA:MDG1Biotechs

Medigene AG (ETR:MDG1) Analysts Just Trimmed Their Revenue Forecasts By 41%

August 10, 2022
One thing we could say about the analysts on Medigene AG ( ETR:MDG1 ) - they aren't optimistic, having just made a...
XTRA:VSCA
XTRA:VSCA
XTRA:VSCABiotechs

We Think 4SC (ETR:VSCA) Can Afford To Drive Business Growth

August 04, 2022
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
XTRA:HPHA
XTRA:HPHA
XTRA:HPHABiotechs

Private equity firms are Heidelberg Pharma AG's (ETR:HPHA) biggest owners and were rewarded after market cap rose by €20m last week

July 22, 2022
Every investor in Heidelberg Pharma AG ( ETR:HPHA ) should be aware of the most powerful shareholder groups. We can see...
XTRA:FYB
XTRA:FYB
XTRA:FYBBiotechs

Analysts Just Published A Bright New Outlook For Formycon AG's (ETR:FYB)

July 13, 2022
Shareholders in Formycon AG ( ETR:FYB ) may be thrilled to learn that the analysts have just delivered a major upgrade...
XTRA:MOR
XTRA:MOR
XTRA:MORBiotechs

Amidst increasing losses, Investors bid up MorphoSys (ETR:MOR) 13% this past week

July 07, 2022
MorphoSys AG ( ETR:MOR ) shareholders should be happy to see the share price up 13% in the last week. But only the...
XTRA:MDG1
XTRA:MDG1
XTRA:MDG1Biotechs

Loss-Making Medigene AG (ETR:MDG1) Set To Breakeven

June 23, 2022
With the business potentially at an important milestone, we thought we'd take a closer look at Medigene AG's ( ETR:MDG1...
XTRA:CNW
XTRA:CNW
XTRA:CNWBiotechs

Breakeven On The Horizon For co.don AG (ETR:CNW)

June 16, 2022
We feel now is a pretty good time to analyse co.don AG's ( ETR:CNW ) business as it appears the company may be on the...
XTRA:FYB
XTRA:FYB
XTRA:FYBBiotechs

Here's Why We're Not Too Worried About Formycon's (ETR:FYB) Cash Burn Situation

May 23, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
  • 1
  • 2
  • 3
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.